Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1401442265;42266;42267 chr2:178634834;178634833;178634832chr2:179499561;179499560;179499559
N2AB1237337342;37343;37344 chr2:178634834;178634833;178634832chr2:179499561;179499560;179499559
N2A1144634561;34562;34563 chr2:178634834;178634833;178634832chr2:179499561;179499560;179499559
N2B494915070;15071;15072 chr2:178634834;178634833;178634832chr2:179499561;179499560;179499559
Novex-1507415445;15446;15447 chr2:178634834;178634833;178634832chr2:179499561;179499560;179499559
Novex-2514115646;15647;15648 chr2:178634834;178634833;178634832chr2:179499561;179499560;179499559
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCA
  • RefSeq wild type template codon: CGT
  • Domain: Ig-90
  • Domain position: 50
  • Structural Position: 127
  • Q(SASA): 0.4322
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/E rs1200308695 -0.761 0.03 N 0.37 0.084 0.149567049428 gnomAD-2.1.1 4.08E-06 None None None None N None 0 0 None 0 0 None 3.41E-05 None 0 0 0
A/E rs1200308695 -0.761 0.03 N 0.37 0.084 0.149567049428 gnomAD-4.0.0 1.60109E-06 None None None None N None 0 0 None 0 0 None 0 0 0 1.4576E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.6498 likely_pathogenic 0.5625 ambiguous -0.813 Destabilizing 0.685 D 0.337 neutral None None None None N
A/D 0.4526 ambiguous 0.3573 ambiguous -0.38 Destabilizing 0.221 N 0.502 neutral None None None None N
A/E 0.2021 likely_benign 0.2331 benign -0.471 Destabilizing 0.03 N 0.37 neutral N 0.432195296 None None N
A/F 0.4568 ambiguous 0.3808 ambiguous -0.756 Destabilizing 0.221 N 0.523 neutral None None None None N
A/G 0.221 likely_benign 0.1685 benign -0.636 Destabilizing 0.058 N 0.323 neutral N 0.42563932 None None N
A/H 0.616 likely_pathogenic 0.556 ambiguous -0.649 Destabilizing 0.518 D 0.451 neutral None None None None N
A/I 0.359 ambiguous 0.2911 benign -0.229 Destabilizing 0.039 N 0.363 neutral None None None None N
A/K 0.6531 likely_pathogenic 0.5992 pathogenic -0.829 Destabilizing 0.039 N 0.376 neutral None None None None N
A/L 0.2733 likely_benign 0.2134 benign -0.229 Destabilizing None N 0.281 neutral None None None None N
A/M 0.2132 likely_benign 0.19 benign -0.356 Destabilizing 0.016 N 0.337 neutral None None None None N
A/N 0.3238 likely_benign 0.254 benign -0.544 Destabilizing 0.221 N 0.504 neutral None None None None N
A/P 0.8055 likely_pathogenic 0.6198 pathogenic -0.272 Destabilizing 0.303 N 0.384 neutral N 0.42509198 None None N
A/Q 0.2303 likely_benign 0.3078 benign -0.729 Destabilizing 0.001 N 0.393 neutral None None None None N
A/R 0.6173 likely_pathogenic 0.5471 ambiguous -0.439 Destabilizing 0.125 N 0.386 neutral None None None None N
A/S 0.0994 likely_benign 0.0883 benign -0.86 Destabilizing 0.002 N 0.244 neutral N 0.426469299 None None N
A/T 0.1194 likely_benign 0.0995 benign -0.852 Destabilizing None N 0.247 neutral N 0.433613584 None None N
A/V 0.1917 likely_benign 0.1486 benign -0.272 Destabilizing 0.03 N 0.32 neutral N 0.430634681 None None N
A/W 0.8386 likely_pathogenic 0.7683 pathogenic -0.98 Destabilizing 0.869 D 0.636 neutral None None None None N
A/Y 0.611 likely_pathogenic 0.5189 ambiguous -0.604 Destabilizing 0.366 N 0.481 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.